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Differential Immune Activation in 
Fetal Macrophage Populations
Omar Lakhdari, Asami Yamamura, Gilberto E. Hernandez, Kathryn K. Anderson, Sean J. Lund, 
Gertrude O. Oppong-Nonterah, Hal M. Hoffman & Lawrence S. Prince
Distinct macrophage subsets populate the developing embryo and fetus in distinct waves. However 
little is known about the functional differences between in utero macrophage populations or how they 
might contribute to fetal and neonatal immunity. Here we tested the innate immune response of mouse 
macrophages derived from the embryonic yolk sac and from fetal liver. When isolated from liver or 
lung, CD11bHI fetal liver derived macrophages responded to the TLR4 agonist LPS by expressing and 
releasing inflammatory cytokines. However F4/80HI macrophages from the yolk sac did not respond 
to LPS treatment. While differences in TLR4 expression did not appear to explain these data, F4/80HI 
macrophages had much lower NLRP3 inflammasome expression compared to CD11bHI macrophages. 
Gene expression profiling also demonstrated LPS-induced expression of inflammatory genes in CD11bHI 
macrophages, but not in F4/80HI cells. Genes expressed in LPS-treated CD11bHI macrophages were 
more likely to contain predicted NF-κB binding sites in their promoter regions. Our data show that 
CD11bHI macrophages derived from fetal liver are the major pro-inflammatory cells in the developing 
fetus. These findings could have important implications in better understanding the fetal inflammatory 
response and the unique features of neonatal immunity.
Macrophages are key components of the innate immune system. Ubiquitous throughout the body, macrophages 
defend against harmful microbes, remove apoptotic cells, and promote tissue repair after injury1. Upon sensing 
microbial products, activated macrophages release inflammatory cytokines and chemokines that recruit addi-
tional inflammatory cells and cause both local and systemic inflammation. A robust inflammatory response by 
macrophages can also lead to significant tissue injury2,3. Dysregulation of macrophage activation and inflamma-
tion contributes to multiple diseases, including atherosclerosis, diabetes, and cancer4–6. When playing a trophic 
role, macrophages can drive tissue fibrosis and tumor growth and metastases7–9. Therefore understanding mac-
rophages and their diverse functions could generate new strategies for combatting human disease.
Tissue macrophages are heterogeneous. For example, the lung contains alveolar macrophages, interstitial mac-
rophages, patrolling monocytes, and airway dendritic cells that originate from macrophage/monocyte precursors. 
The macrophage populations in various tissues appear to arise from unique progenitors during different stages of 
development. Macrophages populate the embryo and fetus in three successive waves10,11. In mice, Csf1r+ eryth-
romyeloid progenitors within the yolk sac endothelium give rise to F4/80HI macrophages throughout the embryo 
beginning at embryonic day 7 (E7). At E9, Myb+ precursors from the yolk sac establish a second site of hemato-
poiesis within the embryonic liver. From the liver, a second wave of CD11bHI macrophages appear around E12, 
differentiate into tissue-specific macrophages, and can persist into adulthood. In the lung, these CD11bHI cells dif-
ferentiate into alveolar macrophages through GM-CSF and TGFβ signaling12,13. A third wave occurs after defin-
itive hematopoiesis moves to the bone marrow, partially replacing embryonic yolk sac derived cells with bone 
marrow derived macrophages via the circulation14. While recent publications have shed new light on the origins 
of macrophage populations, less is known about the functional differences each population plays in immunity.
The fetal and newborn periods present unique immunological challenges. The maternal-fetal immune systems 
must maintain a tolerant state to prevent attack of the developing fetus by the maternal immune system and also 
fetal response against maternal antigens15. Persistence of tolerance after birth may allow colonization of the new-
born with beneficial microbiota and minimize overzealous responses to ingested food antigens16,17. The newborn, 
however, must also be prepared at birth to fend off myriads of microbial pathogens suddenly encountered in the 
ex utero environment. This unique period in immune development renders newborns susceptible to infection 
by opportunistic pathogens18. In addition, an overzealous immune response in the newborn period, especially 
in infants born preterm, leads to serious pathology, chronic developmental abnormalities, and lifelong sequelae.
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In infants born before 30 wk gestation, macrophage-mediated lung inflammation leads to bronchopulmonary 
dysplasia19–23. A chronic developmental lung disease, bronchopulmonary dysplasia is the most common serious 
complication of prematurity. In response to mechanical ventilation, infection, and high oxygen exposure, acti-
vated lung macrophages stimulate inflammation that prevents normal postnatal airway branching and alveolar 
formation24,25. Both patient and animal studies have implicated macrophage-derived IL-1β as a key cytokine 
that drives inflammation, injury, and abnormal structural development22,26,27. IL-1β release requires both NF-κB 
mediated Il1b transcriptional activation and processing of the pro-IL-1β peptide by inflammasome associated 
caspase activity. While multiple inflammasome versions exist, the NLRP3-ASC-CASP1 complex is required for 
lung inflammation and injury in mouse models22,27.
Inflammasome function and IL-1β release in the lung is developmentally regulated. Inflammatory stimuli 
and macrophage activation only impact lung development during later stages of embryonic development22,28. 
The molecular and cellular mechanisms producing this developmental window of susceptibility however are not 
clear. Here we use flow sorting techniques to isolate macrophage populations from embryonic mice and show 
that inflammasome function and IL-1β release is specifically restricted to the population of macrophages derived 
from the fetal liver. By identifying the cell populations that produce tissue inflammation and injury within the 
developing embryo, our findings will lead to more targeting therapeutic approaches for combatting neonatal 
inflammatory diseases.
Material and Methods
Approvals. Animal experiments were approved by the Institutional Animal Care and Use Committee at 
University of California, San Diego. All experimental methods were carried out in accordance with the rules, 
regulations, and guidelines established by the University of California, San Diego Institutional Animal Care and 
Use Program.
Mouse strains. C57BL/6 mice were obtained from Harlan Laboratories. LysM-Cre-NLRP3L351P mice were 
developed and described previously29. The morning of plug identification was defined as embryonic day 0 (E0). 
Embryos were harvested at E13, E15 or E18. Dissections were performed in cold PBS.
Fetal macrophage isolation. Fetal organs (lung, liver, brain) and yolk sacs were collected in cold PBS con-
taining EDTA (2 mM) and fetal bovine serum (FBS-2%). Tissues were homogenized and enzymatically digested 
with collagenase IV (2 mg/ml) for 15 min. red blood cells were lysed with ACK buffer (Life Technologies) for 
5 min. Cells suspensions were passed through a 70-μm cell strainer.
Flow cytometry and cell sorting. Isolated single cell suspensions were first incubated with FC block and 
Zombie NIR or Aqua live/dead stain (Biolegend) for 15 min in PBS. Conjugated antibodies in staining buffer 
(2% FBS + 2%EDTA in PBS) were then added for an additional 30 min incubation. For intracellular staining, 
cells were fixed using IC fixation and permeabilization buffers according to manufacturer’s recommendation 
(eBioscience). The following antibodies were used for flow sorting: CD45-FITC, CD64-Percp-Cy5.5, F4/80-PE 
and CD11b-V450. For flow cytometry analysis and intracellular staining, the following additional antibodies were 
used: CD68-AF647, pro-IL1β-PE-Cy7, TNF-APC-Cy7, NLRP3-APC and CD45-V500.
Flow cytometry measurements were performed on a BD Canto II (BD Biosciences). Sorting was performed 
on a FACS Aria cell sorter. The following gating strategy was used: doublets were excluded based on forward 
scatter-A against forward scatter-W, followed by side scatter-A against side scatter-W. Live cells were selected 
using Zombie LIVE/DEAD stain. CD45+ and CD64+ cells were then selected and further separated based on 
F4/80 and CD11b expression. Yolk sac derived macrophages express higher F4/80 and lower CD11b levels while 
fetal monocytes express lower F4/80 and higher CD11b levels. Sorted cells were cultured in suspension in DMEM 
with 10% FBS with or without gel purified lipopolysaccharide (LPS) from 055:B5 E. coli (Sigma L2637). This 
low-protein preparation of LPS does not appear to activate other Toll-Like Receptors30,31.
RNA isolation and real-time PCR measurement. Cells were homogenized in TRIzol reagent 
(Invitrogen) and RNA was isolated using Direct-Zol RNA miniprep kit (Zymo Research). After RNA isolation, 
cDNA was synthesized using first-strand cDNA synthesis kit (Invitrogen). Real-time PCR was performed in 
CFX96 thermocycler (Bio-Rad) using unlabeled oligonucleotides (IDT) and SYBR Green (Bio-Rad). Gene 
expression data was presented using the 2−ΔCt method, using TBP as reference gene. The sequences of qPCR 
primers used are as followed: Tbp: 5′-ACA TCT CAG CAA CCC ACA CA and 5′-CTG CTG TGG CAG GAG 
TGA TA; Il1b: 5′-GAC CTG TTC TTT GAA GTT GAC GGA CC and 5′-CAA TGA GTG ATA CTG CCT GCC 
TGA AG; Il6: 5′-ACA ACC ACG GCC TTC CCT AC and 5′-ACA ATC AGA ATT GCC ATT GCA C; Nlrp3: 
5′-GAC CAT CGG CCG GAC TAA AA and 5′-CTT GCA CAC TGG TGG GTT TG; Pf4: 5′-CCG AAG AAA 
GCG ATG GAG ATC T and 5′-CCA GGC AAA TTT TCC TCC CA; Igf1: 5′-GTG AGC CAA AGA CAC ACC 
CA and 5′-.ACC TCT GAT TTT CCG AGT TGC.
ELISA. For measurements of IL-1β and IL-6 in culture supernatants, we used the Ready-Set-GO ELISAs kits 
according to manufacturer’s protocol (eBioscience).
Monocyte depletion. For Ly6C+ monocyte depletion, pregnant mice received 3 intraperitoneal injections 
of anti-Ly6G/Ly6C (clone RB6-8C5, Bioxcell) antibody or the isotype control (rat IgG2b anti-KLH, clone LTF-2, 
Bioxcell), starting at E12. For the first injection, mice received 1 mg of antibodies, then 2 mg for the second and 
third injections. Embryos were collected at E15.
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Figure 1. Fetal lung macrophages have differential responses to LPS. (a) Gating strategy used to isolate 
live, CD45+, CD64+ fetal macrophage populations. (b) FACS analysis of E13, E14, and E15 mouse lung 
macrophages (CD45+, CD64+) identified two different macrophage populations beginning at E14 based on 
relative CD11b and F4/80 expression. Percentage of CD45+, CD64+ cells in each population indicated. (c) 
Both CD11bHI and F4/80HI populations expressed the macrophage marker CD68 (red). Isotype control IgG 
staining is included as a control (blue), and the percentage of cells expressing CD68 is indicated. (d) Using the 
differential relative expression of CD11b and F4/80, two different macrophage populations were sorted and 
collected from E15 mouse lungs. After sorting, cells were cultured in suspension under control conditions 
or in the presence of E. coli LPS (O55:B5, gel-purified, 250 ng/ml). After two hours, cells were harvested by 
centrifugation and solubilized in TRIzol. Media was collected for ELISA. Il1b and Il6 mRNA was measured 
by real time PCR; IL-1β and IL-6 in the media was measured by ELISA. Compared to F4/80HI macrophages, 
CD11bHI macrophages expressed higher levels of cytokines both under basal conditions and following LPS 
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Gene expression analysis with Nanostring nCounter technology. The nCounter analysis sys-
tem (NanoString Technologies) was used to assess gene expression by CD11b and F4/80 macrophages. RNA 
from sorted cells was amplified then hybridized with the Mouse Myeloid Innate Immunity Panel v2 (734 
immunology-related mouse genes + 20 internal reference controls) according to manufacturer’s protocol. 
Processing was performed in the UCSD Stem Cell Genomics Core at the Sanford Consortium for Regenerative 
Medicine. Data analysis was performed using nSolver 4.0 according to NanoString guidelines. Raw mRNA counts 
were normalized to account for hybridization efficiency, background noise, and sample content. Genes with mean 
counts less than 20 were excluded, and differential expression of remaining genes was calculated and represented 
on a volcano plot, using a nonparametric t-test and correction for multiple testing using the BH false discov-
ery rate (FDR). Mouse single site analysis of conserved transcription factor (TF) binding sites in the list of dif-
ferentially expressed genes was performed using oPOSSUM 3.0 (http://opossum.cisreg.ca/oPOSSUM3/), using 
JASPAR core profile and the oPOSSUM gene database as background.
Results
CD11bHI fetal lung macrophages are the primary sources of IL-1β and IL-6. Fetal lung inflam-
mation following macrophage activation increases during the later stages of development. Here we tested if this 
temporal change was due to inflammatory differentiation of resident tissue macrophages or appearance of new 
pro-inflammatory cells later in development. Using a flow sorting approach (Fig. 1a), we first demonstrated the 
timing of when different macrophage populations appeared in the developing mouse lung (Fig. 1b). The E13 lung 
contained primarily F4/80HI/CD11bLO (F4/80HI) macrophages (with macrophages defined as CD45+/CD64+). 
These F4/80HI macrophages are derived from myeloid precursor cells in the embryonic yolk sac. Beginning at 
E14, F4/80LO/CD11bHI (CD11bHI) macrophages appeared, derived from fetal liver monocytes. The percentage 
of CD11bHI macrophages increased further at E15. Both CD11bHI and F4/80HI cells expressed the macrophage 
marker CD68 (Fig. 1c).
To test if yolk sac F4/80HI and fetal liver derived CD11bHI lung macrophage populations had distinct func-
tional properties, we sorted both macrophage populations from E15 lungs and stimulated them with the TLR4 
agonist LPS (gel purified from E. coli, O55:B5). Importantly, freshly sorted cells were kept in suspension and 
treated with LPS immediately upon sorting to reduce potential phenotypic changes with cell culture. LPS 
increased both Il1b and Il6 mRNA expression and IL-1β and IL-6 protein release in CD11bHI macrophages 
(Fig. 1d). F4/80HI macrophages expressed very low cytokine mRNA levels and did not release detectable amounts 
of cytokine peptides either under control conditions or upon LPS treatment. We also measured intracellular IL-1β 
and TNF within LPS-treated E15 lung cell suspensions using FACS (Fig. 1e,f). Similar to our real time PCR and 
ELISA data, inflammatory cytokine expression was restricted to CD11bHI lung macrophages and not detected in 
F4/80HI cells. LPS did not significantly increase cell death in either F4/80HI or CD11bHI macrophages as assayed by 
live-dead staining (not shown). CD11bHI macrophages appearing in the fetal lung after E13 were therefore more 
pro-inflammatory after LPS stimulation and with higher cytokine expression and release.
LPS-induced cytokine release is also restricted to CD11bHI macrophages in the fetal liver. To 
test if the functional differences between macrophage populations were tissue specific, we next isolated F4/80HI 
and CD11bHI macrophages from E15 fetal liver and measured their LPS response (Fig. 2a). Similar to lung mac-
rophages, LPS stimulated cytokine expression and release in CD11bHI fetal liver macrophages but not in F4/80HI 
macrophages (Fig. 2b,c). Of note, cytokine expression was lower in E15 liver CD11bHI macrophages compared to 
CD11bHI cells isolated from E15 lung as measured in Fig. 1. We next compared the dose response and time course 
of LPS activation between the two fetal macrophage populations. As shown in Fig. 2d, F4/80HI macrophages failed 
to respond at all LPS concentrations tested. We also did not detect increased Il1b or Il6 mRNA in LPS-treated 
F4/80HI macrophages over a 4 h time course. These data further confirm the proinflammatory phenotype in fetal 
CD11bHI macrophages and the resistance to LPS in fetal F4/80HI macrophages.
To test if the differential response to LPS was present earlier in development, we isolated macrophage pop-
ulations from yolk sac, liver, and lung at E13 (Fig. 3a). LPS did not induce cytokine expression in F4/80HI E13 
macrophages from any of the tissue sources tested. At E13, only the liver contained CD11bHI macrophages, and 
these cells did express IL-1β and IL-6 following LPS treatment. Interestingly, F4/80HI cells from the E13 liver 
appeared to express higher basal levels of Il1b and Il6 mRNA compared to macrophages from yolk sac and lung, 
but cytokine expression did not change with LPS. E13 liver F4/80HI macrophages also did not release cytokine 
peptides into the media after LPS treatment. While both F4/80HI and CD11bHI macrophages populate most tis-
sues within the developing embryo, the brain contains primarily F4/80HI yolk sac macrophages. LPS treatment of 
F4/80HI macrophages from E15 brain did not induce IL-1β expression or release (Fig. 3b), similar to the results 
obtained with other F4/80HI macrophage populations. However F4/80HI brain macrophages did express TNF after 
LPS treatment. The unique brain microenvironment therefore appears to promote at least a partially competent 
inflammatory state in F4/80HI macrophages.
Based on these data, we hypothesized that CD11bHI macrophages were the primary inflammatory cells in the 
developing embryo. To test the requirement of CD11bHI macrophages in mediating inflammation, we injected 
treatment (+/− s.e.m.; *P < 0.05, **P < 0.01, ***P < 0.001; n = 5–8). (e,f) Measurement of IL-1β and TNF 
expression in fetal lung macrophages by intracellular immunostaining and FACS. Single cell suspensions from 
E15 mouse lungs were treated with LPS for 2 h followed by fixation, staining, and FACS. LPS induced higher 
IL-1β and TNF expression in CD11bHI macrophages compared to F4/80HI macrophages (+/− s.e.m.; *P < 0.05, 
**P < 0.01, n = 3).
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Figure 2. Differential response to LPS between fetal liver macrophage populations. (a) E15 fetal mouse livers 
contain both CD11bHI and F4/80HI macrophage populations that also express CD68 (red). Isotype control IgG 
staining is included as a control (blue) and the percentage of cells expressing CD68 is indicated. (b) In sorted 
CD11bHI macrophages from E15 liver, LPS increased IL-1β and IL-6 gene expression and cytokine release into 
the media. However, LPS did not increase expression or release in F4/80HI macrophages. (+/− s.e.m.; *P < 0.05, 
**P < 0.01, n = 4–7). (c) Intracellular immunostaining and FACS analysis only detected pro-IL-1β and TNF 
in CD11bHI macrophages. F4/80HI cells did not express either cytokine, even following LPS treatment. Data 
shown are from a single experiment representative of three independent experiments. (d) Dose response data 
measuring Il1b and Il6 expression by real time PCR in CD11bHI and F4/80HI macrophage populations treated 
for 4 h with 0, 10 ng/ml, 50 ng/ml, or 250 ng/ml LPS (n = 3). (e) Time course of the LPS response (250 ng/ml) in 
both CD11bHI and F4/80HI macrophage populations (n = 3).
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pregnant dams with monoclonal anti-Gr-1 IgG to immunodeplete CD11bHI cells from developing embryos32,33. 
Figure 4 shows that anti-Gr-1 injection reduced the number of Ly6C+/CD11bHI macrophages in the fetal liver at 
E15. When the total liver cell suspension was treated with LPS, Gr-1 depleted samples had reduced levels of IL-1β 
and IL-6 release equivalent with the level of depletion (Fig. 4a,b). These data supported CD11bHI macrophages 
as a major population of cells in the fetal liver releasing IL-1β and IL-6 following LPS treatment. While anti-Gr-1 
IgG immunodepleted Ly6C+ cells from the E15 lung, the number of CD11bHI macrophages was unchanged 
(Fig. 4c,d). LPS stimulated IL-1β and IL-6 release was unaffected by anti-Gr-1 depletion in E15 lung samples, 
consistent with our hypothesis that CD11bHI macrophages were the main cellular source of IL-1β.
Tlr4 and Nlrp3 inflammasome expression in CD11bHI fetal macrophages. IL-1β expression and 
release following LPS exposure requires both TLR4 signaling and NLRP3 inflammasome expression, assem-
bly, and activation. We next tested if fetal lung macrophage populations had differential TLR4 or NLRP3 
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Figure 3. (a) LPS responsiveness is only present in CD11bHI macrophages as early as E13. Macrophage 
populations from E13 mouse lung, yolk sac, and liver were sorted, isolated, and stimulated with LPS. Only 
F4/80HI macrophages could be isolated from E13 lung and yolk sac. LPS did not increase cytokine expression 
or release from E13 F4/80HI macrophages (+/− s.e.m.; *P < 0.05, n = 3–7). (b) F4/80HI macrophages in E15 
mouse brains have a partial response to LPS. The majority of macrophages in E15 brain were F4/80HI, and LPS 
treatment did not increase IL-1β release or mRNA expression (+/− s.e.m.; n = 6–7). Intracellular staining and 
FACS did demonstrate increased TNF expression in F4/80HI macrophages from E15 brain, but only minimal 
pro-IL-1β expression (representative data from three independent experiments shown).
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expression. CD11bHI macrophages from the lung did express higher levels of TLR4 compared to F4/80HI mac-
rophages (Fig. 5a,c). However E15 liver macrophage populations expressed similar TLR4 levels (Fig. 5b,c). 
Potential differences in TLR4 expression therefore did not appear to explain why F4/80HI macrophages failed 
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Figure 4. Depletion of CD11bHI/Ly6C+ macrophages reduces IL-1β production in E15 fetal liver. Pregnant 
mice were injected with nonimmune IgG or anti-GR-1 antibody. At E15, macrophages were isolated from fetal 
liver (a,b) and fetal lung (c,d) Anti-Gr-1 injection reduced the percentage of CD11bHI/Ly6C+ macrophages 
in the E15 fetal liver (a) with a corresponding reduction in IL-1β and IL-6 release following treatment of the 
total fetal liver cell suspension with LPS (*P < 0.05, n = 3; **P < 0.01, n = 4, ***P < 0.001, n = 4). Anti-Gr-1 
injections did not reduce CD11bHI/Ly6C+ macrophages from fetal lungs or reduce IL-1β or IL-6 production 
following LPS treatment.
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to express inflammatory cytokines after LPS treatment. NLRP3 expression in the developing lung is restricted 
to macrophages and increases during the later stages of lung development. CD11bHI macrophages from E15 
lung expressed higher Nlrp3 compared to F4/80HI macrophages (Fig. 6a). LPS increased Nlrp3 expression in 
CD11bHI cells with minimal effect on F4/80HI macrophages. Similar results were seen by immunostaining mac-
rophages with antibodies against NLRP3 and the inflammasome linker protein ASC (Fig. 6b). Expression and 
co-localization were more prevalent in CD11bHI cells. LPS treatment increased co-localization in both mac-
rophage populations, with much higher ASC-NLRP3 co-localized signal in CD11bHI macrophages (Fig. 6c).
We next tested if constitutively active NLRP3 was sufficient to drive cytokine release in both CD11bHI and 
F4/80HI macrophages. We isolated E15 liver macrophages from Nlrp3L351P mice expressing a gain of function 
mutation within the Nlrp3 gene. At E15, neither macrophage population released significant IL-1β under control 
conditions (Fig. 6d,e). LPS treatment however stimulated both IL-1β and IL-6 release only in CD11bHI mac-
rophages. F4/80HI macrophages from E15 Nlrp3L351P mice failed to express high levels of NLRP3 by confocal 
immunofluorescence, even after LPS treatment (Fig. 6f). Nlrp3L351P CD11bHI macrophages expressed both NLRP3 
and ASC, with expression and colocalization increased after LPS treatment. Consistent with our data in wild type 
macrophages, these results show that fetal CD11bHI macrophages express NLRP3 inflammasome components 
and have the capacity to express and release IL-1β upon TLR4 stimulation. F4/80HI macrophages however failed 
to express NLRP3, preventing their ability to release IL-1β. Coupled with the lack of both Il1b and Il6 mRNA 
in F4/80HI macrophages, these data suggest that F4/80HI macrophages lack an innate immune transcriptional 
response as well as the machinery necessary for generating pro-inflammatory activation.
Differential myeloid gene expression in LPS-treated fetal macrophages. The above experiments 
focused on Il1b, Il6, and Nlrp3 in initially assessing the LPS-induced inflammatory response in F4/80HI and 
CD11bHI fetal macrophages. To measure expression of additional genes, we used Nanostring nCounter gene 
expression profiling of 734 myeloid genes in LPS treated F4/80HI and CD11bHI macrophages from E15 mouse 
lung (Fig. 7a). A total of 89 genes were differentially expressed between the 2 macrophage populations (log2 fold 
change >1; adjusted P < 0.05). CD11bHI cells expressed higher levels of Il1a, Il1b, Ccl9, and Cxcl3, while F4/80HI 
cells had higher expression of Pf4 (also known as Cxcl4), Igf1, and the complement genes C1qa, C1qb and C1qc 
(Fig. 7a). Real time PCR confirmed higher C1qa and Pf4 expression in F4/80HI macrophages and LPS did not 
increase expression of either gene (Fig. 7b). To identify the molecular mechanisms of differential gene expression 
in the two macrophage populations, we examined TF binding sites enriched in LPS-induced genes in CD11bHI 
macrophages compared to F4/80HI macrophages using Opossum 3.0 (Fig. 7c). Overexpressed genes in CD11bHI 
macrophages were notably enriched in NF-κB binding sites, while the F4/80HI macrophage gene signature con-
tained motifs predicted to bind SRF, IRF1, and IRF2. In addition, RUNX1 predicted sites in F4/80HI samples were 
consistent with data showing Runx1 expression is restricted to yolk sac derived macrophages34. In summary, our 
data suggest fetal macrophage populations have inherent differences in the transcriptional response machinery 
following exposure to LPS.
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were immunolabeled with anti-TLR and analyzed by FACS. (c) TLR4-APC median fluorescence intensity 
(MFI) values measured TLR4 surface expression in each macrophage population. While CD11bHI macrophages 
from E15 lung appeared to express higher levels of TLR4 compared to F4/80HI lung macrophages, the relative 
expression of TLR4 in liver macrophage populations was similar (+/− s.e.m.; ***P < 0.001 compared to IgG 
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Discussion
Fetal lung inflammation is developmentally regulated, with macrophage activation and cytokine release impact-
ing airway morphogenesis only during the later stages of in utero development22. Here we show that developmen-
tal regulation of lung inflammation is due to the programmed accumulation of pro-inflammatory macrophages 
in the lung after E15. While we and others have shown macrophages do populate the lung from the initial days 
of embryonic development12,23,35, these early yolk sac derived macrophages appear resistant to pro-inflammatory 
TLR mediated activation. Our data here clearly demonstrate the functional differences between F4/80HI yolk sac 
derived macrophages and CD11bHI fetal liver derived macrophages. CD11bHI macrophages express higher levels 
of inflammasome components and release IL-1β and IL-6 upon LPS treatment, while F4/80HI macrophages fail to 
release these inflammatory mediators that play important roles in injury and disease.
Macrophage populations may share common functional properties in the moments following their differ-
entiation from myeloid progenitors during fetal hematopoiesis. Upon trafficking to the circulation and into 
various tissues, the local microenvironment then shapes macrophage biology and promotes specialized, tissue 
specific functions11,36. While the adult lung contains multiple immune cell populations including dendritic cells 
and lymphocytes, many of these cells appear after birth37,38. However we still have not determined the relative 
heterogeneity within the various fetal macrophage populations studied here. At E15 when fetal liver derived 
CD11bHI macrophages are first trafficking to various tissues, cells isolated from the fetal lung had a slightly higher 
expression of inflammatory cytokines compared to cells still residing within the liver. The high levels of GM-CSF 
present in the lung could mediate these differences39. F4/80HI cells from the yolk sac, liver, and lung remained 
resistant to LPS stimulation. The strikingly different situation identified for F4/80HI cells is the developing fetal 
brain. Macrophages in the fetal brain are primarily F4/80HI cells from the yolk sac, and these cells eventually 
differentiate into microglia34,40. Not only do brain microglia have inflammatory potential, they also play a key 
role in forming mature synapses41–43. Interestingly, F4/80HI macrophages from the E15 fetal brain did respond to 
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Real time PCR measured higher Nlrp3 mRNA levels in LPS treated CD11bHI macrophages compared to F4/80HI 
macrophages in both E15 lung and E15 liver (+/− s.e.m.; *P < 0.05, n = 3–5). (b) CD11bHI macrophages from 
fetal liver expressed higher levels of NLRP3 and the linker protein ASC compared to F4/80HI macrophages 
as visualized by laser scanning confocal microscopy. (c) LPS increased NLRP3-ASC colocalization in both 
macrophage populations. For colocalization measurements, pixel intensities in the red, green, and yellow 
(colocalized) channels were measured in identically sized regions of interest. Higher pixel intensity was 
measured in CD11bHI macrophages (+/− s.e.m.; *P < 0.05, n = 3). (d,e) Macrophage populations were sorted 
from E15 LysM-Nlrp3L351P inflammasome gain of function mice and treated with LPS. IL-1β (d) and IL-6 (e) 
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LPS by increasing TNF expression. However they appeared to lack functional NLRP3 inflammasome expression 
and therefore failed to release IL-1β. Identifying the factors within the brain that give F4/80HI cells their unique 
functional properties could provide important insight into both macrophage biology and neuroinflammatory 
disease processes.
The functional differences between fetal macrophage populations suggest unique molecular regulatory 
mechanisms. While both macrophage populations expressed similar levels of the LPS receptor TLR4, F4/80HI 
macrophages did not express the same levels of NF-κB dependent genes after LPS treatment. Therefore F4/80HI 
macrophages could have reduced expression of proteins required for the TLR-IKK-NF-κB or MAPK signaling 
pathways. Differential transcription factor expression or epigenetic chromatin modifications between CD11bHI 
and F4/80HI macrophages could also explain why LPS generated unique responses in each cell population. Our 
informatics analysis clearly identified NF-κB promoter sites activated in CD11bHI macrophages that were appar-
ently not accessible in F4/80HI cells. Ongoing experiments are exploring the potential upstream mechanisms 
responsible for these differences.
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1 1Scientific RepoRts |          (2019) 9:7677  | https://doi.org/10.1038/s41598-019-44181-8
www.nature.com/scientificreportswww.nature.com/scientificreports/
If CD11bHI cells mount inflammatory responses to microbes in the developing embryo, then what are the 
roles of F4/80HI macrophages? F4/80HI cells migrate throughout the entire embryo very early in development. 
The ubiquitous locations and lack of TLR-mediated inflammatory function suggest they play a role in tissue 
morphogenesis or homeostasis. Macrophages remove dying and apoptotic cells from both developing and mature 
tissues44. Multiple receptors on phagocytic cells bind outer leaflet phosphatidylserine on apoptotic and necrotic 
cells45. The complement component C1q promotes phagocytosis of dying cells by macrophages46–48. We meas-
ured higher levels of the C1q genes C1qa, C1qb, and C1qc in F4/80HI macrophages from fetal lung compared to 
CD11bHI macrophages. These data suggest that yolk sac derived F4/80HI macrophages play important roles in 
removing apoptotic or necrotic cells during tissue morphogenesis. F4/80HI macrophages also expressed IGF-1, 
a major promoter of both developmental morphogenesis and tissue repair and regeneration. Macrophage IGF-1 
contributes to muscle repair following injury49. In the lung, macrophage phagocytosis of apoptotic cells in the 
lung releases IGF-1, which then stimulates additional phagocytic function in adjacent airway epithelial cells50. 
The transcription factors MafB and C/EBPγ were both detected in Nanostring analysis of F4/80HI macrophages, 
and both factors drive anti-inflammatory cell phenotypes51,52. Data therefore suggest that anti-inflammatory fetal 
F4/80HI macrophages could be tasked with removing damaged cells and cellular debris during morphogenesis 
while pro-inflammatory CD11bHI macrophages respond to microbial products and innate immune activators.
The unique functions of fetal macrophage populations could impact disease processes. Early in develop-
ment, the lack of proinflammatory macrophages prevents a robust innate immune response. Upon appearance 
of activation competent CD11bHI macrophages in various tissues, TLR activation can lead to regional or sys-
temic inflammation in the developing fetus. Future experiments will need to implement novel approaches for 
depleting specific fetal macrophage populations, as our antibody-based strategy was inefficient at cell depletion. 
Intrauterine fetal inflammation plays a major role in causing preterm birth and the long-term sequelae of extreme 
prematurity53. Inflammatory processes and tissue injury are associated with necrotizing enterocolitis54, bron-
chopulmonary dysplasia55, and retinopathy of prematurity56. If our data in mice translate to the development of 
human innate immunity, interventions targeting macrophage activation and inflammation processes will need to 
focus on specific pro-inflammatory macrophage populations.
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